Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
Eli Lilly(LLY) stock is priced at $1,069.56, giving the company a market capitalization of 1T. It carries a P/E multiple of 38.34 and pays a dividend yield of 58.5%.
On 2026-05-26, Eli Lilly(LLY) stock traded between a low of $1,060.36 and a high of $1,081.99. Shares are currently priced at $1,069.56, which is +0.9% above the low and -1.1% below the high.
The Eli Lilly(LLY)'s current trading volume is 2.98M, compared to an average daily volume of 2.91M.
In the last year, Eli Lilly(LLY) shares hit a 52-week high of $1,133.95 and a 52-week low of $623.78.
In the last year, Eli Lilly(LLY) shares hit a 52-week high of $1,133.95 and a 52-week low of $623.78.
LLY News
The pharma company is booming due to innovative treatments. Will AI create the world's first trillionaire? Our team just released a report on the one little-kn...
Eli Lilly Spends Nearly Four Billion Dollars on Vaccine Expansion Pharmaceutical giant Eli Lilly announced plans to acquire three vaccine developers in deals w...
Eli Lilly (LLY) stock is rising on news that the company is acquiring multiple vaccine makers for nearly $4 billion in cash. Unlock trusted, data-backed invest...
Analyst ratings
85%
of 33 ratingsMore LLY News
Stock futures rose Tuesday as markets reacted to reports of potential progress in U.S.–Iran talks aimed at ending the conflict, with sentiment supported by Pres...
How Eli Lilly's Next-Gen Obesity Drug Is 'Raising The Bar' In Weight Loss 5/21/2026 Patients lost up to 85 pounds in a study of Eli Lilly's next-generation wei...
BofA raised the firm’s price target on Eli Lilly (LLY) to $1,251 from $1,133 and keeps a Buy rating on the shares. The firm expects Lilly’s overall revenue and...
Eli Lilly (LLY) is expanding into infectious-disease prevention through acquisitions of vaccine developers Curevo, LimmaTech Biologics, and Vaccine Co. in deals...
What Triggered The Reaction On Monday, Lilly reported positive Phase 1b data for VERVE-102, an investigational in vivo base editing medicine designed to permane...
Eli Lilly (LLY) is back in the spotlight after its investigational obesity drug retatrutide hit strong Phase 3 trial milestones, showing high and durable weight...
Key Points Eli Lilly just reported strong results for a next-generation GLP-1 drug that it is developing. GLP-1 developments in India aren't headline-grabbing...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.